Why consider China for advanced cancer treatment?
Short answer. China is a global pioneer in CAR-T cell therapy and runs a large share of the world's CAR-T clinical trials. Its leading hospitals also offer proton and heavy-ion therapy, next-generation immunotherapy and robotic surgery. Delegata arranges treatment on request at top-tier, internationally accredited university hospitals in Beijing and Shanghai.
Patients often look to China for treatments that are not yet widely available or approved in Western markets. Streamlined regulatory pathways mean approved and trial-phase cell therapies can be reached faster than in many other regions. CAR-T is used mainly for blood cancers such as leukaemia, lymphoma and multiple myeloma, and trials are under way for solid tumours. Not every patient is a candidate. A Delegata physician reviews your records first and says plainly if another option suits you better.
How does Delegata arrange treatment in China?
Short answer. A Delegata physician reviews your records, then matches your case to the right sub-specialist and hospital. You receive the plan, timeline and price in writing before you commit. Delegata then coordinates translation of your records, admission, travel, visa paperwork and a local medical interpreter, and stays in touch after you return home.
The first step is a 30-minute consultation with a physician advisor, from AED 300, credited toward the arrangement fee. Delegata's own fee is confirmed in writing and kept separate from hospital costs. Treatment such as CAR-T usually means a stay of several weeks near the hospital, so Delegata plans accommodation for you and a companion. Clinical responsibility stays with the treating doctors. Delegata coordinates, advocates and keeps your records private.
Is treatment in China safe?
Short answer. At the right hospital, yes, but CAR-T itself carries known serious side effects, such as cytokine release syndrome and neurological effects. It should only be given by an experienced team that can manage them. Delegata works only with top-tier, internationally accredited university hospitals in Beijing and Shanghai and confirms the treating team in writing.
JCI accreditation is an international standard for hospital quality and patient safety. A Delegata physician reviews your case before any hospital is proposed and checks that the treatment fits your diagnosis and history. You see the team, the plan and the price in writing first. A local medical interpreter stays with you during admission and key appointments. After you return home, Delegata relays questions to the treating team and arranges follow-up. If treatment in China is the wrong answer, Delegata says so.

